Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-12

Clinical Trial Update: Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma

View source ↗

Summary

A clinical trial update exploring vitamin D supplementation and sun exposure in patients who had surgery for melanoma (stages IB, II, or IIIA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (cholecalciferol) supplementation (cholecalciferol)

Snippet

Sponsor: Leeds Cancer Centre at St. James's University Hospital | Conditions: Melanoma (Skin) | Status: UNKNOWN